Effects of antihistamines on the function of human α7-nicotinic acetylcholine receptors

Eur J Pharmacol. 2015 Jan 5:746:308-16. doi: 10.1016/j.ejphar.2014.10.046. Epub 2014 Nov 8.

Abstract

Effects of the histamine H₁ receptor (H1R) antagonists (antihistamines), promethazine (PMZ), orphenadrine (ORP), chlorpheniramine (CLP), pyrilamine (PYR), diphenhydramine (DPH), citerizine (CTZ), and triprolidine (TRP) on the functional properties of the cloned α7 subunit of the human nicotinic acetylcholine receptor expressed in Xenopus oocytes were investigated. Antihistamines inhibited the α7-nicotinic acetylcholine receptor in the order PYR>CLP>TRP>PMZ>ORP≥DPH≥CTZ. Among the antihistamines, PYR showed the highest reversible inhibition of acetylcholine (100 µM)-induced responses with IC₅₀ of 6.2 µM. PYR-induced inhibition was independent of the membrane potential and could not be reversed by increasing the concentration of acetylcholine. Specific binding of [¹²⁵I] α-bungarotoxin, a selective antagonist for α7-nicotinic acetylcholine receptor, was not changed in the presence of PYR suggesting a non-competitive inhibition of nicotinic receptors. In line with functional experiments, docking studies indicated that PYR can potentially bind allosterically with the α7 transmembrane domain. Our results indicate that the H₂-H₄ receptor antagonists tested in this study (10 µM) showed negligible inhibition of α7-nicotinic acetylcholine receptors. On the other hand, H₁ receptor antagonists inhibited the function of human α7-nicotinic acetylcholine receptor, with varying potencies. These results emphasize the importance of α7-nicotinic acetylcholine receptor for future pharmacological/toxicological profiling.

Keywords: Antihistamine; Nicotinic acetylcholine receptor; Pyrilamine; Xenopus oocyte.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allosteric Regulation
  • Animals
  • Binding Sites
  • Cells, Cultured
  • Histamine H1 Antagonists / chemistry
  • Histamine H1 Antagonists / metabolism
  • Histamine H1 Antagonists / pharmacology*
  • Histamine H2 Antagonists / chemistry
  • Histamine H2 Antagonists / metabolism
  • Histamine H2 Antagonists / pharmacology
  • Histamine H3 Antagonists / chemistry
  • Histamine H3 Antagonists / metabolism
  • Histamine H3 Antagonists / pharmacology
  • Humans
  • Ketamine / chemistry
  • Ketamine / metabolism
  • Ketamine / pharmacology
  • Kinetics
  • Models, Molecular*
  • Molecular Conformation
  • Molecular Docking Simulation
  • Nerve Tissue Proteins / antagonists & inhibitors*
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism
  • Oocytes / cytology
  • Oocytes / drug effects
  • Oocytes / metabolism
  • Protein Structure, Tertiary
  • Pyrilamine / chemistry
  • Pyrilamine / metabolism
  • Pyrilamine / pharmacology*
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / metabolism
  • Xenopus laevis
  • alpha7 Nicotinic Acetylcholine Receptor / antagonists & inhibitors*
  • alpha7 Nicotinic Acetylcholine Receptor / genetics
  • alpha7 Nicotinic Acetylcholine Receptor / metabolism

Substances

  • Chrna7 protein, human
  • Histamine H1 Antagonists
  • Histamine H2 Antagonists
  • Histamine H3 Antagonists
  • Nerve Tissue Proteins
  • Recombinant Proteins
  • alpha7 Nicotinic Acetylcholine Receptor
  • Ketamine
  • Pyrilamine